Last reviewed · How we verify
NCT06558318
TMJ Dysfunction: Effects on Proprioception, Pain, and Body Awareness
trial testing Assessment of temporomandibular dysfunction in Temporomandibular Joint Disorders in 60 participants. Completed in 19 January 2025.
19 December 2024
Quick facts
| Lead sponsor | Nagihan Acet |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 19 August 2024 |
| Primary completion | 19 December 2024 |
| Estimated completion | 19 January 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Assessment of temporomandibular dysfunction
Conditions studied
- Temporomandibular Joint Disorders — all drugs for Temporomandibular Joint Disorders →
- Temporomandibular Disorder — all drugs for Temporomandibular Disorder →
Sponsor
Nagihan Acet
Who can join
Adults 18 to 25, any sex, with Temporomandibular Joint Disorders or Temporomandibular Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The term "temporomandibular joint dysfunction" (TMJ dysfunction) refers to a range of anatomical and functional problems, with or without clinical signs and symptoms, that affect the TMJ and/or the chewing muscles. It is more frequent in women and young people ages between 20 and 40. Its frequency ranges from 28% to 88%. The term "temporomandibular joint dysfunction" (TMJ dysfunction) refers to a range of anatomical and functional problems, with or without clinical signs and symptoms, that affect the TMJ and/or the chewing muscles. It is more frequent in women and young people ages between 20 and 40. Its frequency ranges from 28% to 88%. This condition is frequently disregarded because of inadequate diagnosis . Additionally, TMJ dysfunction can particularly emerge in the early stages without the presence of pain. Due to the insidious onset of the disease, especially in the early stages, other TMJ-related factors, in addition to pain-related parameters, need to be considered.Therefore, the aim of the study is to investigate the effect of TME disorder on proprioception, body awareness, and pain-related parameters including pain threshold, pain tolerance, and temporal summation in young adults.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06558318
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Temporomandibular Joint Disorders
Currently open trials in the same condition.
- NCT07317570 — The Effect of Body Awareness Therapy on Pain, Function and Psychosocial Parameters in Temporomandibular Joint Disorders · NA · recruiting
- NCT06763419 — Internal Photobiomodulation For Management Of Temporomandibular Joint Internal Derangement · NA · recruiting
- NCT06721104 — Balance, TMJ, Social Adaptive Assessment in Individuals With Autism Spectrum Disorder · recruiting
- NCT06500390 — Temporomandibular Disorder in Use of Levonorgestrel Intrauterine System · NA · recruiting
- NCT06813040 — Efficacy of Repetitive Transcranial Magnetic Stimulation in Temporomandibular Disorders. · NA · recruiting
Other Nagihan Acet trials
Trials by the same sponsor.
- NCT06689319 — Factors Linked to AI Literacy in University Students · completed
- NCT06634238 — Acute Mask Effects on Walk Distance and Vital Signs · not yet recruiting
- NCT06603493 — Headaches: Effects on Sleep, Sensitization, and Psychological Factors · completed
- NCT06598774 — Cervical Parameters and Body Awareness in Relation to Smartphone Addiction · completed
- NCT06559397 — Proprioceptive Puzzle: Effects on Quantitative Sensory Tests and Body Awareness · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06558318 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nagihan Acet
- Last refreshed: 25 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06558318.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing